Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 2/20 | 0.68 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.68 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.68 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.68 |
| ▸ | F2 | P00734 | 1/20 | 0.68 |
| ▸ | PKM | P14618 | 3/20 | 0.66 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.63 |
| ▸ | CA12 | O43570 | 2/20 | 0.58 |
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | ABL1 | P00519 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | IDE | P14735 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL890035 | 1.00 | PRSS1 (0.68) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL18117435 | 1.00 | PRSS1 (0.68) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL12551869 | 1.00 | PRSS1 (0.68) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL21531161 | 1.00 | PRSS1 (0.68) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL19952819 | 1.00 | PRSS1 (0.68) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL24974563 | 1.00 | PRSS1 (0.68) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL24670280 | 1.00 | PRSS1 (0.68) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL24163378 | 1.00 | PRSS1 (0.68) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL21151130 | 1.00 | PRSS1 (0.68) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL13021124 | 1.00 | PRSS1 (0.68) | PRSS1PRSS2PRSS3TPSAB1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4146744-A1 | HETERO-FUNCTIONAL COATING FOR CONJUGATING BIOMOLECULES ON A SOLID SUPPORT AND USE THEREOF FOR BIOANALYSIS | Waters Technologies Corporation (US) | 2023-03-15 | — | — | EP | claimed |
| CN-115551956-A | Heterofunctional coating for conjugating biomolecules on solid supports and use thereof for bioanalysis | 沃特世科技公司 | 2022-12-30 | — | — | CN | claimed |
| US-20260147001-A1 | PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260118364-A1 | PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES | GLYPHIC BIOTECHNOLOGIES INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4731263-A1 | BIO-CONJUGATES FOR ONCOLOGY | RDP Pharma AG (CH) | 2026-04-29 | — | — | EP | disclosed |
| US-12534718-B2 | Separating polynucleotide fragments | ILLUMINA, INC. (US) | 2026-01-27 | — | — | US | disclosed |
| US-20250367307-A1 | PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | TORAY INDUSTRIES, INC. (JP) | 2025-12-04 | — | — | US | disclosed |
| EP-4652458-A1 | SYSTEMS AND METHODS FOR MULTIPLEX DETECTION OF BIOMARKERS | Veravas, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| US-20250295796-A1 | CELL PENETRATING POLYPEPTIDES (CPPS) AND THEIR USE IN HUMAN THERAPY | PAGS CO., LTD. (KR) | 2025-09-25 | — | — | US | disclosed |
| US-20250281630-A1 | PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | TORAY INDUSTRIES, INC. (JP) | 2025-09-11 | — | — | US | disclosed |
| US-12399180-B2 | Protein sequencing via coupling of polymerizable molecules | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2025-08-26 | — | — | US | disclosed |
| WO-2023033129-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER | 東レ株式会社 | 2023-03-09 | — | — | WO | disclosed |
| US-20230060588-A1 | METHODS OF AMELIORATING AND/OR PREVENTING CORONAVIRUS-RELATED INFECTIONS | Glycure LLC (US) | 2023-03-02 | — | — | US | disclosed |
| US-20220326210-A1 | ENHANCED CHEMICAL AND BIOLOGICAL DETECTIONS WITH SIZE-SHRINKABLE HYDROGELS | NORTHEASTERN UNIVERSITY | 2022-10-13 | — | — | US | disclosed |
| US-11422129-B2 | Method and device to optimize analyte and antibody substrate binding by least energy adsorption | SQI DIAGNOSTICS SYSTEMS INC. (CA) | 2022-08-23 | — | — | US | disclosed |
| US-20220242933-A1 | ANTIBODIES AND FC FUSION PROTEIN MODIFICATIONS WITH ENHANCED PERSISTENCE OR PHARMACOKINETIC STABILITY IN VIVO AND METHODS OF USE THEREOF | THE JACKSON LABORATORY (US) | 2022-08-04 | — | — | US | disclosed |
| US-20220202837-A1 | COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-06-30 | — | — | US | disclosed |
| US-20220186310-A1 | MULTIVALENT BINDING COMPOSITION FOR NUCLEIC ACID ANALYSIS | ELEMENT BIOSCIENCES, INC. | 2022-06-16 | — | — | US | disclosed |
| US-11278554-B2 | Compositions and methods for modification of biomolecules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-03-22 | — | — | US | disclosed |
| US-20220072118-A1 | IMMUNOGENIC COMPOSITIONS | AFFINIVAX, INC. | 2022-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230060588-A1 | METHODS OF AMELIORATING AND/OR PREVENTING CORONAVIRUS-RELATED INFECTIONS | FUT5, FUT6, SIGLEC7 | PRSS1 189/4885PRSS2 216/4885PRSS3 204/4885 |
| US-20220202837-A1 | COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES | PTMS, QPCT, ANPEP | PRSS1 3042/4885PRSS2 3575/4885PRSS3 1477/4885 |
| US-12534718-B2 | Separating polynucleotide fragments | DNASE1, TENT4B, TNS4 | PRSS1 729/4885PRSS2 152/4885PRSS3 401/4885 |
| US-20250367307-A1 | PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | CAPRIN1, NOS1, NCBP1 | PRSS1 1049/4885PRSS2 2706/4885PRSS3 1815/4885 |
| US-20260118364-A1 | PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES | SPPL2B, SPPL2A, MAX | PRSS1 1669/4885PRSS2 1308/4885PRSS3 1438/4885 |
| US-11278554-B2 | Compositions and methods for modification of biomolecules | PTMS, QPCT, ANPEP | PRSS1 3042/4885PRSS2 3575/4885PRSS3 1477/4885 |
| US-20260147001-A1 | PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES | SPPL2A, SPPL2B, PTMS | PRSS1 2004/4885PRSS2 1391/4885PRSS3 1304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.